

Health News.
Comprehensive men's sexual health information, tips and news about men's sexual health.
Archive for the 'Women’s Health' Category
With the onset of puberty, the female reproductive system matures, and the development of secondary sex characteristics transforms young girls into young women. The first sign of puberty is the development of breast buds, which occurs around age 11. Body fat heavily influences the onset of puberty, and increasing rates of obesity in children may account for the fact that girls here and in other countries seem to be reaching puberty much earlier than they used to. Under the direction of the endocrine system, the pituitary gland, the hypothalamus, and the ovaries all secrete hormones that act as chemical messengers among them. Working in a feedback system, hormonal levels in the bloodstream act as the trigger mechanism for release of more or different hormones.At around the age of 9 1/2 to 11 1/2 in females, the hypothalamus receives the message to begin secreting gonadotropin-releasing hormone (GnRH). The release of GnRH in turn signals the pituitary gland to release hormones called gonadotropins. Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are two gonadotropins, and their role is to signal the gonads, in this case the ovaries, to start producing estrogens and progesterone. Increased estrogen levels assist in the development of female secondary sex characteristics. In addition, estrogens are responsible for regulating the reproductive cycle. The normal age range for the onset of the first menstrual period, termed the menarche, is 9 to 17 years, with the average age being 11 1/2 to 13 1/2 years. Obese girls tend to begin menstruation much earlier than average, and very thin girls tend to begin menstruation much later, as is often the case with young, female athletes.The average menstrual cycle is 28 days long and divided into three phases: the proliferatory phase, the secretory phase, and the menstrual phase. During the proliferatory phase, the pituitary gland releases FSH and LH. The FSH acts on the ovaries to stimulate the maturation process of several ovarian follicles (egg sacs). These follicles secrete estrogens and, in response to this estrogen stimulation, the lining of the uterus, the endometrium, begins to grow and develop. The inner walls of the uterus become coated with a thick, spongy lining composed of blood and mucus. In the event of fertilization, the endometrial tissue will become a nesting place for the developing embryo. The increased estrogen level also signals the pituitary to slow down FSH production but to increase LH secretion. Of the several follicles developing in the ovaries, only one each month normally reaches complete maturity. Under the influence of LH, this one ovarian follicle rapidly matures, and on or about the fourteenth day of the proliferatory phase, it releases an ovum into the fallopian tube – a process referred to as ovulation. Just prior to ovulation, the mature egg’s follicle begins to increase secretion of progesterone, the first function of which is to spur the addition of further nutrients to the developing endometrium.After ovulation, the ovarian follicle is converted into the corpus luteum, or yellow body, which continues to secrete estrogen and progesterone but in decreasing amounts. In addition, FSH also falls back to its preproliferatory levels. Essentially, the woman’s body is “waiting” to see whether fertilization will occur. During this time after ovulation, LH declines, and progesterone levels begin to rise, causing additional tissue growth in the endometrium. This phase of the cycle is called the secretory phase.If fertilization takes place, cells surrounding the developing embryo release a hormone called human chorionic gonadotropin (HCC). This hormone leads to increased levels of estrogen and progesterone secretion, which maintains the endometrium while signaling the pituitary gland not to start a new menstrual cycle.When fertilization does not occur, the egg gradually disintegrates within approximately 72 hours. The corpus luteum gradually becomes nonfunctional, causing levels of progesterone and estrogen to decline. As hormonal levels decline, the endometrial lining of the uterus loses its nourishment, dies, and is sloughed off as menstrual flow. Menstruation is the third phase of the menstrual cycle.Some issues associated with menstruation that you may be interested in reading about are premenstrual syndrome (PMS), toxic shock syndrome (TSS), and dysmenorrhea, or painful menstruation.*4/277/5*
read comments (0)WOMEN AND SMOKING
Author: admin
For more than 50 years, tobacco company advertisements have enticed women to smoke cigarettes. Though their messages have glamorized smoking, the real results are not very glamorous: women who smoke have an increased risk of developing cancer, heart disease, and problems associated with the reproductive organs. The risk of cervical cancer, for instance, is higher among women who smoke than among those who don’t. A woman reduces her risk dramatically when she quits.
According to a recent study, cigarettes are more dangerous to women than to men; women are more likely to develop lung cancer and to do so with fewer cigarettes. Already lung cancer has surpassed breast cancer death for women. The risk of heart disease for women smokers who smoke more than 25 cigarettes per day is 500 percent higher than it is for nonsmokers. Even smoking one to four cigarettes per day doubles a woman’s risk for heart attack. It makes no difference if she smokes low- or high-nicotine cigarettes.
Smoking appears to cause women to begin menopause one to two years early. Yet former smokers start menopause at about the same age as women who have never smoked. Smoking also contributes to osteoporosis, a condition involving bone loss that particularly afflicts women. Current female smokers age 35 and older are more than 10 times as likely to die of emphysema or chronic bronchitis than male smokers.
Women who take oral contraceptives (birth control pills) and who smoke cigarettes greatly increase their risk of heart attack. In a recent study, the risk for a heart attack was shown to be 20 times higher for pill users who smoked 10 or more cigarettes per day than it was for women who did not smoke and did not use the pill. Oral contraceptives increase the risk of developing blood clots, which can block the already narrowing arteries of women with atherosclerosis, another disease with an increased risk for smokers. For these reasons, smoking while taking oral contraceptives also increases the risk of peripheral vascular disease and stroke.
Although cigarette smoking is dangerous for all women, it presents special risks for pregnant women and their fetuses. Each year in the United States, approximately 50,000 miscarriages are attributed to smoking during pregnancy. On average, babies born to mothers who smoke weigh less than those born to nonsmokers, and low birth-weight is correlated with many developmental problems. Pregnant women who stop smoking in the first three or four months of their pregnancies give birth to higher-birth-weight babies than do women who smoke throughout their pregnancies. Prenatal exposure to smoking has also been linked with impairments in memory, learning, cognition, and perception in the growing child. Infant mortality rates are also higher among babies born to smokers.
Maternal smoking has long been linked to increased risk of sudden infant death syndrome (SIDS). S1DS, or “crib death,” occurs when an infant, usually less than 1 year of age, dies during its sleep for no apparent reason. The increased risk is associated with how much the mother smokes. Passive smoke has also been associated with significant increases in risk of SIDS. This risk is increased in normal-weight infants, about twofold with passive smoke exposure, and about threefold when the mother smokes both during the pregnancy and after the baby is born. Infants who are born to mothers who smoke during pregnancy have more episodes of apnea and excessive sweating. We do not know exactly how smoking affects the infant during the pregnancy, but it has been suggested that smoking may influence the development of the nervous system.
One study found that daughters of women who smoked during pregnancy are four times more likely to begin smoking during adolescence and to continue smoking than the daughters of women who did not smoke while pregnant. The study suggests that nicotine, which crosses the placental barrier, may affect the female fetus during an important period of development so as to predispose the brain to the addictive influence of nicotine more than a decade later.
39/277/5*
MYOMECTOMY FOR FIBROIDS (PART 2)
Author: admin
The formation of adhesions — a risk of any abdominal surgery — must be avoided if possible because of the associated pain and interference with normal organ function. Tissues that were never meant to be joined can become attached to each other and problems like chronic pelvic pain and infertility may result. To minimise the chances of adhesions forming, tissues must be handled gently, appropriate irrigation solutions or an adhesion barrier used within the abdomen, and blood loss minimised. The extra cost to the patient of taking these precautions is less than $150, a small price to pay for the prevention of potentially serious problems. The use of laser techniques and diathermy also appears to reduce the risk of adhesion formation. Reconstruction of the uterus after removal of fibroids requires skill and care. Recent research suggests that when sutures are avoided during myomectomy, adhesions are less likely to develop. On the other hand, the absence of sutures may lead to weakness of the uterus.
An occasional serious complication of hysteroscopic myomectomy is perforation of the uterus. It may occur if the surgeon cuts deeply into the wall of the uterus to remove parts of an embedded fibroid. To minimise the risk of this happening, some doctors simultaneously perform a laparoscopy, a procedure in which a small incision in the abdomen is used as a porthole to enable visual inspection of the pelvic organs, including the outside wall of the uterus. Others think this is of doubtful value. Most women return home within one to three days of a hysteroscopic or laparoscopic myomectomy and it is usual for surgeons to check on each patient’s progress about six weeks later.
For open myomectomy, the pattern of post-operative illness and time to full recovery is similar to that for abdominal hysterectomy. That is, the average length of hospital stay is four to seven days, pain persists for several weeks and full recovery may take several months.
Women having a hysteroscopic or laparoscopic myomectomy experience less pain and a shorter convalescence (by about two to four weeks) than those having either open myomectomy or abdominal hysterectomy. The cost of these procedures in Australia is considerably less, in the short-term at least, than the cost of an open myomectomy (around $1500 for hysteroscopic myomectomy and $2200 for a laparoscopic myomectomy compared to $3825 for an open myomectomy). Because of the relatively recent introduction of hysteroscopic and laparoscopic techniques to perform myomectomy, it will be some time before we know the extent to which fibroid recurrence and complications alter these costings.
*42\198\4*
There are many ways of testing nutritional status – using samples of blood or sweat, for instance. But one of the most cost-effective and convenient ways is through a hair sample. Hair has been shown to reflect a good long-term record of our mineral and nutritional experience.
Eventually hair samples could be used to screen for potential diabetes or breast cancer. Work is being undertaken in Australia by Professor Veronica James at the University of New South Wales where hair is being analyzed with a technique called X-ray diffraction. As X-rays are fired through the hair they form a pattern on photographic film. From this pattern the researchers are able to pick up different information. For instance, with hair from a diabetic patient, sugar binds onto the hair filaments. It will therefore look different from a strand of hair taken from a person without diabetes.
Hair samples can also be used to test for drug use, such as cocaine, amphetamines and cannabis. This is helpful in forensic medicine and pathology, for example to determine whether somebody was under the influence of drugs in an accident.
Because your hair cells are some of the fastest-growing cells in your body, they can ‘lock in’ information about your exposure to certain nutrients as they grow. In this way, your hair forms a permanent record of your exposure to beneficial and toxic elements. Analyzing hair is therefore also an excellent way to test for heavy toxic metals and is used in many medical studies to assess exposure to metals like mercury.
Other ways of testing, with blood or urine for instance, can be less reliable, because the results are influenced by what you may have eaten. Also your body tries to keep everything in balance. To do this, it tops up the levels of nutrients in your blood by taking them from elsewhere. For instance, if your blood calcium levels fall your body will pinch calcium from your bones to keep the level constant. A blood test may then suggest that your calcium levels are fine. But a hair analysis showing high levels of calcium would help identify the leeching of calcium from your bones.
However, like any testing method, hair analysis has its limitations. For instance, when testing for nutrients it is important that your hair is not contaminated by tints, highlights or perms. Certain minerals (iron, for instance) are best tested by blood samples. But levels of trace elements can be higher in hair, which make them easier to analyze. Also, because hair doesn’t need specialized sampling equipment or storage, this form of testing is accessible for couples who don’t live near a qualified practitioner.
Hair can be used to analyze your levels of calcium, magnesium, zinc, selenium, copper, manganese, chromium and also the toxic metals mercury, aluminum and cadmium.
The minerals are usually analyzed, together with a detailed questionnaire.
Then a personalized programme of supplements is recommended for you and your partner. This programme should be followed for a minimum of four months and then the hair should be re-tested.
Once your mineral and toxic levels are back to normal, you will be given a maintenance programme to follow until you become pregnant.
In the twelfth week of pregnancy, you will be tested again. Your nutrient needs during pregnancy are different and your programme will be adjusted accordingly. You should then continue with the amended programme until you have your baby.
If your starting levels of nutrients were very deficient or your toxic metal levels extremely high, then you should stay on the programme for longer.
If you are planning to have fertility treatment, you should follow the programme for four months beforehand. This will ensure that the egg and sperm are as healthy as they can be before treatment starts, to give the procedure the best possible chance of working.
Mineral analysis can also identify substances that reduce your and your partner’s fertility. For example, if you have used the pill or an IUD (coil) you may have high levels of copper. This can also be due to fertility treatment, where the drugs used increase copper levels. High levels of copper are a concern, as they are often matched by low zinc levels which can dramatically affect levels of fertility and may also give an increased rate of miscarriage.
You and your partner may turn out to have high levels of copper and other toxic metals and this may well explain your fertility problems.
*59/73/5*
IS THERE AN EFFECTIVE TREATMENT FOR IMPOTENCE?
Author: admin
Failure of sexual function in men can sometimes be due to a deficiency of male sex hormones, and this deficiency can be diagnosed by fairly simple laboratory tests. If a deficiency is present, treatment with the male sex hormone can be given. There is no simple tablet or pill as there is for the treatment of women; testosterone (male sex hormone) must be given by injection or implants every 10-14 days. It should be stressed that this treatment is indicated only for a minority of men with decreased sexual function, but for such men the treatment usually causes remarkable improvement. For other men, in whom no sex hormone deficiency can be shown, treatment with a male sex hormone is usually of no benefit.
There should, perhaps, be one note of caution. Male sex hormones are known to act on the prostate, and if a man already has some prostatic problem with urinary difficulties, testosterone may aggravate it.
Is there a clinic for men who have these problems? Not at present. A good physician will often recognise the problem, and may refer such men to endocrinologists (which deal with glandular problems). These clinics can only determine whether there is a hormonal deficiency or not, and advise about treatment with male sex hormones.
If there is no deficiency of male sex hormones, a referral might he made to a sexual counseling clinic. Such clinics have been established to help men (couples really) with importence and other problems.
*55\63\8*
